Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
01/2003
01/16/2003WO2002087759B1 Polymer-bound catalyst for the enantioselective aldol or mannich reaction
01/16/2003WO2002041984A3 Catalytic compositions and methods for asymmetric aldol reactions
01/16/2003US20030013894 Comprises conversion of oxalamide to dithiooxalamide, followed by conversion of the dithiooxalamide to either a 4,5-bisimino-(1,3)dithiolane or 2,3-bisimino-(1,4)dithiane
01/16/2003US20030013857 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties
01/16/2003US20030013847 Pyruvate derivatives
01/16/2003US20030013846 Cytoprotective agents
01/16/2003US20030013757 Aromatic dicarboxylic acid derivatives
01/16/2003US20030013754 Antiinflamamtory agents
01/16/2003US20030013741 Antihistamines; antiallergens
01/16/2003US20030013725 Amino acid derivatives
01/16/2003US20030013714 Sleep disorders; eating disorders; sexual disorders; hypotensive agents
01/16/2003US20030013700 Thrombin inhibitors
01/16/2003US20030013677 Anticancer agents
01/16/2003US20030013657 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents
01/16/2003US20030013656 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents
01/16/2003US20030013603 Catalyst for oxidation, carbonylation, nitration, sulfonation
01/16/2003US20030009835 Comprises oxidation base such as 1-N,N-bis(3',4'-dihydroxybutyl)-para-phenylenediamine; oxidative hair color dyes
01/16/2003CA2521993A1 Crystalline forms of ¬r-(r*,r*)|-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-¬(phenylamino)carbonyl|-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin)
01/16/2003CA2453211A1 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
01/16/2003CA2452686A1 Arylamines for the treatment of conditions associated with gsk-3
01/16/2003CA2451159A1 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives
01/16/2003CA2450857A1 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use
01/16/2003CA2448917A1 Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof
01/15/2003EP1275641A2 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
01/15/2003EP1275301A1 Trisubstituted heterocyclic compounds and their use as fungicides
01/15/2003EP1274682A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
01/15/2003EP1274678A1 Novel alpha-sulfin- and alpha-sulfonamido acid amides
01/15/2003EP1274423A1 Medicine for treating traumatic brain injury and other neuronal disorders
01/15/2003EP0889031B1 Simple process for producing high-quality captopril
01/15/2003EP0862571B1 Herbicidal sulfonamides
01/15/2003EP0820451B1 Novel heterocyclic compounds
01/15/2003EP0713483B1 Amidine derivatives with nitric oxide synthetase activities
01/15/2003CN1391565A Benzophenones as inhibitors of reverse transcriptase
01/15/2003CN1391473A VLA-4 inhibitor compounds
01/15/2003CN1391469A Npyy5拮抗剂 Npyy5 antagonist
01/15/2003CN1390833A 2,5-cis-bisubstituted pyrrolidine derivative and its preparing process and usage
01/15/2003CN1098849C 噻唑衍生物 Thiazole derivatives
01/15/2003CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents
01/14/2003US6506906 Preparation and use of bifunctional molecules having DNA sequence binding specificity
01/14/2003US6506894 Solution phase synthesis of oligonucleotides
01/14/2003US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
01/14/2003US6506796 Cosmetically or therapeutically treating diseases or disorders in cell populations whose pathology is linked to an inadequate rate of apoptosis by administering a therapeutically effective amount of
01/14/2003US6506788 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
01/14/2003US6506759 Retroviral protease inhibitors
01/14/2003US6506517 Surface modified carbonaceous materials
01/14/2003US6506459 Coating compositions containing alkoxy substituted perfluoro compounds
01/09/2003WO2003002596A2 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders
01/09/2003WO2003002595A2 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
01/09/2003WO2003002553A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
01/09/2003WO2003002531A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
01/09/2003WO2003002530A2 Pyrrolidines as dipeptidyl peptidase inhibitors
01/09/2003WO2003002522A1 Peptide deformylase inhibitors
01/09/2003WO2003002519A1 Phenol derivatives and their use in medicaments
01/09/2003WO2003002491A2 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
01/09/2003WO2002062777A9 Amino ceramide-like compounds and therapeutic methods of use
01/09/2003WO2001072728B1 Novel piperazine derivatives
01/09/2003US20030009056 Process for the removal of nitrobenzenesulfonyl
01/09/2003US20030009032 For inhibiting the replication or infectivity of a virus; therapy
01/09/2003US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
01/09/2003US20030008910 Use of proteasome inhibitors to treat dry eye disorders
01/09/2003US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives
01/09/2003US20030008874 1,3 disubstituted pyrrolidines as alpha -2- adrenoceptor antagonists
01/09/2003CA2450722A1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
01/09/2003CA2424645A1 New use of dipeptidyl peptidase iv inhibitors
01/09/2003CA2418543A1 New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
01/08/2003EP1273571A1 Nitrogenous compounds and antiviral drugs containing the same
01/08/2003EP1272567A2 Mono- and bis-hydrazone pigments
01/08/2003EP1272467A1 Cathepsin cysteine protease inhibitors
01/08/2003EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors
01/08/2003EP1272178A2 Bilirubin or biliverdin degradation fragments
01/08/2003EP1272175A2 Il-8 receptor antagonists
01/08/2003EP1242521A4 Recovery of modifier compounds and polar organic compounds from a poly(arylene sulfide) recycle mixture
01/08/2003EP1124819B1 Method of lithiating five-membered heterocycles
01/08/2003EP0996439B1 Beta-alkoxyacrylates against malaria
01/08/2003EP0915881B1 Pyrroloazepine compounds
01/08/2003CN1389459A Optical breaking process of d1-trans-4-phenyl-5-O-chlorobenzyl pyrrolidone-2
01/08/2003CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
01/07/2003US6504036 2- and 2.5-substituted phenylketoenols
01/07/2003CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease
01/03/2003WO2003000647A1 (ethylene)-(propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents
01/03/2003WO2003000250A1 3-fluoro-pyrrolidines as antidiabetic agents
01/03/2003WO2003000249A1 Function regulator for retinoid relative receptor
01/03/2003WO2003000198A2 Selective neuronal nitric oxide synthase inhibitors
01/03/2003WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes
01/03/2003CA2450579A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
01/03/2003CA2449441A1 3-fluoro-pyrrolidines as antidiabetic agents
01/02/2003US20030004337 Efficient lactam synthesis
01/02/2003US20030004308 Anticoagulants
01/02/2003US20030004208 Squalene synthetase inhibitors; antilipemic agents, anticholesterol agents
01/02/2003US20030004186 Anticoagulants; cardiovascular disorders; central nervous system disorders
01/02/2003US20030004138 Hypoglycemic agents; antidiabetic agents; dietetics
01/02/2003EP1270562A2 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof
01/02/2003EP1268455A2 Piperazine derivatives
01/02/2003EP1268454A1 Succinoylamino heterocycles as inhibitors of a-beta protein production
01/02/2003EP1268453A1 Estrogen agonist/antagonist metabolites
01/02/2003EP1268420A1 Chemokine receptor antagonists
01/02/2003EP1268419A1 Pyrrolidine derivatives useful as bax inhibitors
01/02/2003EP1268418A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
01/02/2003EP1268414A1 Ceramide derivatives and method of use
01/02/2003EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives